Pittsburgh, PA – According to filings with the U.S. Securities and Exchange Commission, Apollo Neuroscience is raising $7,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Kathryn Fantauzzi played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Apollo Neuroscience

Apollo Neuro is scientifically sound, wearable touch therapy that you wear on your ankle or wrist. Apollo’s silent, soothing vibrations speak to your nervous system, telling you that you’re safe and in control. Developed by neuroscientists and physicians, it’s a non-invasive, effective stress relief tool for adults and children, without drugs or side effects. Rather than tracking your health, Apollo Neuro is proven to actively improve it. As Apollo strengthens and rebalances your autonomic nervous system, your heart rate variability (HRV) improves which means you’re building your resilience to stress. So you spend less time in fight-or-flight mode and get more time to rest and digest. Over time, your body learns to recover from stress more quickly, so you can relax, sleep better, and find deep, meaningful focus û anytime and anywhere. Like a workout for your nervous system, consistency is key. The more you use it, the better it works.

To learn more about Apollo Neuroscience, visit http://apolloneuro.com/

Contact:
Kathryn Fantauzzi, Chief Executive Officer
518-312-0567
kathryn@apolloneuro.com
https://www.linkedin.com/in/kathryn-fantauzzi-b444ba1a/

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved